ReviewHematology. American Society of Hematology. Education Program2023

Selection of bispecific antibody therapies or CAR-T cell therapy in relapsed lymphomas.

Ajay Major et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.